Does Dr. HIYAD AL-HUSAINI have financial conflicts of interest?

Dr. HIYAD AL-HUSAINI (MD) has received a total of $228 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $228 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. HIYAD AL-HUSAINI?

According to CMS Open Payments data, Dr. HIYAD AL-HUSAINI received funding from ACELRX PHARMACEUTICALS ($118), INTEGRA LIFESCIENCES CORPORATION ($90), and KOWA PHARMACEUTICALS AMERICA ($20).

Does Dr. HIYAD AL-HUSAINI receive research grants or speaking fees?

Dr. HIYAD AL-HUSAINI has received $228 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. HIYAD AL-HUSAINI

MDReal-Time Hydrated

Specialty: Plastic Surgery

Practice Location: BRONXVILLE, NY 10708

NPI Number: 1770543035

LIFETIME INDUSTRY VALUE

$228

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AL-HUSAINI is a verified Plastic Surgery practitioner based in BRONXVILLE, NY.

Between 2021 and 2025, Dr. AL-HUSAINI had an overall industry promotional and research financial footprint of $228 as recorded in the federal CMS Open Payments database.

$228 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AL-HUSAINI's primary funding source is ACELRX PHARMACEUTICALS, which accounts for $118 (representing 51.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ACELRX PHARMACEUTICALS

Rank 1

$118

51.8%

INTEGRA LIFESCIENCES CORPORATION

Rank 2

$90

39.6%

KOWA PHARMACEUTICALS AMERICA

Rank 3

$20

8.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.